Showing results (61-70 of 136) with videos related to

Sort By:
Pageof 14
Statistics in Medicine|June 22, 2010
Comparative effectiveness research: Policy context, methods development and research infrastructureSean R Tunis, Joshua Benner, Mark McClellan
Journal of General Internal Medicine|January 4, 2019
Payment Reform, Medication Use, and Costs: Can We Afford to Leave Out Drugs?Natasha Parekh, Mark McClellan, William H Shrank
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|July 1, 2015
Shifting Away From Fee-For-Service: Alternative Approaches to Payment in GastroenterologyKavita Patel, Elise Presser, Meaghan George, et al.
Journal of Managed Care & Specialty Pharmacy|June 26, 2020
Preclinical Alzheimer Disease Drug Development: Early Considerations Based on Phase 3 Clinical TrialsAnna Hung, Monika Schneider, Marianne Hamilton Lopez, et al.
Eukaryotic Cell|September 6, 2011
Evolutionary dynamics of Candida albicans during in vitro evolutionMian Huang, Mark McClellan, Judith Berman, et al.
Yeast (Chichester, England)|July 11, 2012
Analysis of protein function in clinical C. albicans isolatesMaryam Gerami-Nejad, Anja Forche, Mark McClellan, et al.
Toxicological Sciences : an Official Journal of the Society of Toxicology|June 25, 2005
Workshop proceedings: managing conflict of interest in science. A little consensus and a lot of controversyJacques P Maurissen, Steven G Gilbert, Miriam Sander, et al.
Circulation|October 26, 2005
Mortality after acute myocardial infarction in hospitals that disproportionately treat black patientsJonathan Skinner, Amitabh Chandra, Douglas Staiger, et al.
The American Journal of Medicine|March 15, 2002
The relation between managed care market share and the treatment of elderly fee-for-service patients with myocardial infarctionPaul A Heidenreich, Mark McClellan, Craig Frances, et al.
Pageof 14